Aeglea Biotherapeutics shares owned by Stempoint Capital
Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Stempoint Capital
from 13F filings
Historical chart of Stempoint Capital investment in Aeglea Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aeglea Biotherapeutics held by Stempoint Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Aeglea Biotherapeutics by Stempoint Capital
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-06-30 | $3.5M | 151k | 23.51 |
2024-03-31 | $2.4M | 62k | 37.93 |